Global Meglumine Diatrizoate Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Meglumine Diatrizoate Injection Market Size, Share and Analysis

The global Meglumine Diatrizoate Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Meglumine injection, indicated as this contrast agent for intravenous and retrograde urography; Cerebral, thoracic, abdominal and limbs angiography, venography and CT; It can also be used for arthrography, fistula imaging, hysterosalpingography, endoscopic retrograde cholangiopancreatography (ERCP), sialography, and other tests. Meglumine injection should not be used in selective coronary angiography. It should not be used for myelography, ventriculography, or cisternography as it may induce neurotoxic symptoms. The major consumer markets for Meglumine Diatrizoate Injection are North America, Europe and the Asia-Pacific region. With the gradual recovery of the global economy after the COVID-19 outbreak and the return of major economies to normal, the medical industry will see certain growth. As the global medical level continues to improve, more and more hospitals and clinics are able to perform MRI and CT imaging. Therefore, the demand for Meglumine Diatrizoate Injection will increase in the foreseeable time. Infinity Market Research newest research report, the Meglumine Diatrizoate Injection Industry Forecast looks at past sales and reviews total world Meglumine Diatrizoate Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Meglumine Diatrizoate Injection sales for 2025 through 2031. With Meglumine Diatrizoate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meglumine Diatrizoate Injection industry. This Insight Report provides a comprehensive analysis of the global Meglumine Diatrizoate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meglumine Diatrizoate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Meglumine Diatrizoate Injection market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meglumine Diatrizoate Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meglumine Diatrizoate Injection. This report presents a comprehensive overview, market shares, and growth opportunities of Meglumine Diatrizoate Injection market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; 1ml/0.3g &nbsp;&nbsp;&nbsp; 20ml/15.2g &nbsp;&nbsp;&nbsp; 20ml/12g &nbsp;&nbsp;&nbsp; 100ml/60g Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic &nbsp;&nbsp;&nbsp; Pharmacy This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; AdvaCare Pharma &nbsp;&nbsp;&nbsp; Shanghai Xudong Haipu Pharmaceutical &nbsp;&nbsp;&nbsp; Hunan Hansen Pharmaceutical &nbsp;&nbsp;&nbsp; Shanghai Bracco Sine Pharmaceutical &nbsp;&nbsp;&nbsp; Lunan Pharmaceutical &nbsp;&nbsp;&nbsp; Xian Hanfeng Pharmaceutical Key Questions Addressed in this Report What is the 10-year outlook for the global Meglumine Diatrizoate Injection market? What factors are driving Meglumine Diatrizoate Injection market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Meglumine Diatrizoate Injection market opportunities vary by end market size? How does Meglumine Diatrizoate Injection break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Meglumine Diatrizoate Injection Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Meglumine Diatrizoate Injection by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Meglumine Diatrizoate Injection by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Meglumine Diatrizoate Injection Segment by Type &nbsp;2.2.1 1ml/0.3g &nbsp;2.2.2 20ml/15.2g &nbsp;2.2.3 20ml/12g &nbsp;2.2.4 100ml/60g &nbsp;2.3 Meglumine Diatrizoate Injection Sales by Type &nbsp;2.3.1 Global Meglumine Diatrizoate Injection Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Meglumine Diatrizoate Injection Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Meglumine Diatrizoate Injection Sale Price by Type (2020-2025) &nbsp;2.4 Meglumine Diatrizoate Injection Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinic &nbsp;2.4.3 Pharmacy &nbsp;2.5 Meglumine Diatrizoate Injection Sales by Application &nbsp;2.5.1 Global Meglumine Diatrizoate Injection Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Meglumine Diatrizoate Injection Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Meglumine Diatrizoate Injection Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Meglumine Diatrizoate Injection Breakdown Data by Company &nbsp;3.1.1 Global Meglumine Diatrizoate Injection Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Meglumine Diatrizoate Injection Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Meglumine Diatrizoate Injection Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Meglumine Diatrizoate Injection Revenue by Company (2020-2025) &nbsp;3.2.2 Global Meglumine Diatrizoate Injection Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Meglumine Diatrizoate Injection Sale Price by Company &nbsp;3.4 Key Manufacturers Meglumine Diatrizoate Injection Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Meglumine Diatrizoate Injection Product Location Distribution &nbsp;3.4.2 Players Meglumine Diatrizoate Injection Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Meglumine Diatrizoate Injection by Geographic Region &nbsp;4.1 World Historic Meglumine Diatrizoate Injection Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Meglumine Diatrizoate Injection Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Meglumine Diatrizoate Injection Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Meglumine Diatrizoate Injection Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Meglumine Diatrizoate Injection Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Meglumine Diatrizoate Injection Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Meglumine Diatrizoate Injection Sales Growth &nbsp;4.4 APAC Meglumine Diatrizoate Injection Sales Growth &nbsp;4.5 Europe Meglumine Diatrizoate Injection Sales Growth &nbsp;4.6 Middle East & Africa Meglumine Diatrizoate Injection Sales Growth 5 Americas &nbsp;5.1 Americas Meglumine Diatrizoate Injection Sales by Country &nbsp;5.1.1 Americas Meglumine Diatrizoate Injection Sales by Country (2020-2025) &nbsp;5.1.2 Americas Meglumine Diatrizoate Injection Revenue by Country (2020-2025) &nbsp;5.2 Americas Meglumine Diatrizoate Injection Sales by Type (2020-2025) &nbsp;5.3 Americas Meglumine Diatrizoate Injection Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Meglumine Diatrizoate Injection Sales by Region &nbsp;6.1.1 APAC Meglumine Diatrizoate Injection Sales by Region (2020-2025) &nbsp;6.1.2 APAC Meglumine Diatrizoate Injection Revenue by Region (2020-2025) &nbsp;6.2 APAC Meglumine Diatrizoate Injection Sales by Type (2020-2025) &nbsp;6.3 APAC Meglumine Diatrizoate Injection Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Meglumine Diatrizoate Injection by Country &nbsp;7.1.1 Europe Meglumine Diatrizoate Injection Sales by Country (2020-2025) &nbsp;7.1.2 Europe Meglumine Diatrizoate Injection Revenue by Country (2020-2025) &nbsp;7.2 Europe Meglumine Diatrizoate Injection Sales by Type (2020-2025) &nbsp;7.3 Europe Meglumine Diatrizoate Injection Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Meglumine Diatrizoate Injection by Country &nbsp;8.1.1 Middle East & Africa Meglumine Diatrizoate Injection Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Meglumine Diatrizoate Injection Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Meglumine Diatrizoate Injection Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Meglumine Diatrizoate Injection Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Meglumine Diatrizoate Injection &nbsp;10.3 Manufacturing Process Analysis of Meglumine Diatrizoate Injection &nbsp;10.4 Industry Chain Structure of Meglumine Diatrizoate Injection 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Meglumine Diatrizoate Injection Distributors &nbsp;11.3 Meglumine Diatrizoate Injection Customer 12 World Forecast Review for Meglumine Diatrizoate Injection by Geographic Region &nbsp;12.1 Global Meglumine Diatrizoate Injection Market Size Forecast by Region &nbsp;12.1.1 Global Meglumine Diatrizoate Injection Forecast by Region (2026-2031) &nbsp;12.1.2 Global Meglumine Diatrizoate Injection Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Meglumine Diatrizoate Injection Forecast by Type (2026-2031) &nbsp;12.7 Global Meglumine Diatrizoate Injection Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 AdvaCare Pharma &nbsp;13.1.1 AdvaCare Pharma Company Information &nbsp;13.1.2 AdvaCare Pharma Meglumine Diatrizoate Injection Product Portfolios and Specifications &nbsp;13.1.3 AdvaCare Pharma Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 AdvaCare Pharma Main Business Overview &nbsp;13.1.5 AdvaCare Pharma Latest Developments &nbsp;13.2 Shanghai Xudong Haipu Pharmaceutical &nbsp;13.2.1 Shanghai Xudong Haipu Pharmaceutical Company Information &nbsp;13.2.2 Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications &nbsp;13.2.3 Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Shanghai Xudong Haipu Pharmaceutical Main Business Overview &nbsp;13.2.5 Shanghai Xudong Haipu Pharmaceutical Latest Developments &nbsp;13.3 Hunan Hansen Pharmaceutical &nbsp;13.3.1 Hunan Hansen Pharmaceutical Company Information &nbsp;13.3.2 Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications &nbsp;13.3.3 Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Hunan Hansen Pharmaceutical Main Business Overview &nbsp;13.3.5 Hunan Hansen Pharmaceutical Latest Developments &nbsp;13.4 Shanghai Bracco Sine Pharmaceutical &nbsp;13.4.1 Shanghai Bracco Sine Pharmaceutical Company Information &nbsp;13.4.2 Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications &nbsp;13.4.3 Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Shanghai Bracco Sine Pharmaceutical Main Business Overview &nbsp;13.4.5 Shanghai Bracco Sine Pharmaceutical Latest Developments &nbsp;13.5 Lunan Pharmaceutical &nbsp;13.5.1 Lunan Pharmaceutical Company Information &nbsp;13.5.2 Lunan Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications &nbsp;13.5.3 Lunan Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Lunan Pharmaceutical Main Business Overview &nbsp;13.5.5 Lunan Pharmaceutical Latest Developments &nbsp;13.6 Xi'an Hanfeng Pharmaceutical &nbsp;13.6.1 Xi'an Hanfeng Pharmaceutical Company Information &nbsp;13.6.2 Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications &nbsp;13.6.3 Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Xi'an Hanfeng Pharmaceutical Main Business Overview &nbsp;13.6.5 Xi'an Hanfeng Pharmaceutical Latest Developments 14 Research Findings and Conclusion

Report	Global Meglumine Diatrizoate Injection Market Growth, Trends and Opportunities 2025-31
Selected License	Multi ID: LPI49790

Buyer Information

Order Summary